Page last updated: 2024-08-26

10-hydroxy-2-decenoic acid and Osteoporosis

10-hydroxy-2-decenoic acid has been researched along with Osteoporosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hayashi, M; Iwata, T; Kamakura, M; Nagamatsu, K; Nakashima, T; Ono, T; Tsuchiya, Y	1

Other Studies

1 other study(ies) available for 10-hydroxy-2-decenoic acid and Osteoporosis

Article	Year
The key royal jelly component 10-hydroxy-2-decenoic acid protects against bone loss by inhibiting NF-κB signaling downstream of FFAR4. The Journal of biological chemistry, 2020, 08-21, Volume: 295, Issue:34 Topics: Animals; Cell Differentiation; Disease Models, Animal; Fatty Acids; Fatty Acids, Monounsaturated; Female; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteoporosis; RANK Ligand; Receptors, G-Protein-Coupled; Signal Transduction	2020

Article

Year

The key royal jelly component 10-hydroxy-2-decenoic acid protects against bone loss by inhibiting NF-κB signaling downstream of FFAR4.

The Journal of biological chemistry, 2020, 08-21, Volume: 295, Issue:34

Topics: Animals; Cell Differentiation; Disease Models, Animal; Fatty Acids; Fatty Acids, Monounsaturated; Female; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteoporosis; RANK Ligand; Receptors, G-Protein-Coupled; Signal Transduction

2020